EBLASAKIMAB
UNII O5BD04085Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Eblasakimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) O5BD04085Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2445460-16-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
O5BD04085Y
CAS Registry Number
2445460-16-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EBLASAKIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C184861
National Cancer Institute reference terminology for clinical and research data.
INN ID
11881
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Eblasakimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EBLASAKIMAB

Common Names & Synonyms

EBLASAKIMAB [INN]
EBLASAKIMAB [WHO-DD]
IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN INTERLEUKIN 13 RECEPTOR IL13RA1) (HUMAN MONOCLONAL ASLAN004 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ASLAN004 .KAPPA.-CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus